Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are among the most common risk factors in PD with the most common pathogenic variant LRRK2 G2019S accounting for about 5% of familial PD cases [69]. The gene discussed is LRRK2; the disease is Parkinson disease.